CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro
Abstract Introduction The HER2 + tumor immune microenvironment is composed of macrophages, natural killer cells, and tumor infiltrating lymphocytes, which produce pro-inflammatory cytokines. Determining the effect of T-cells on HER2 + cancer cells during therapy could guide immunogenic therapies tha...
Main Authors: | Patrick N. Song, Ameer Mansur, Kari J. Dugger, Tessa R. Davis, Grant Howard, Thomas E. Yankeelov, Anna G. Sorace |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-020-01625-w |
Similar Items
-
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer
by: Meghan J. Bloom, et al.
Published: (2020-04-01) -
TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis
by: Mingcan Yang, et al.
Published: (2020-06-01) -
Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation
by: Vitalyi Senyuk, et al.
Published: (2019-01-01) -
Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
by: Xiao Tian, et al.
Published: (2017-10-01) -
CD4+ Th1 to the rescue in HER-2+ breast cancer
by: Lea Lowenfeld, et al.
Published: (2019-10-01)